Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm|Neoplasm Metastasis
Interventions: PROCEDURE: Autologous T cells|DRUG: Interleukin-2
Sponsor: National Cancer Institute (NCI)